Financial Ratios Biogen Inc.

Equities

BIIB

US09062X1037

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:00:00 2025-12-05 pm EST			5-day change	1st Jan Change
181.30 ^USD	-0.37%		-0.43%	+18.56%

Dec. 05	Stoke Therapeutics, Inc. and Biogen Inc. Present Data That Further Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome	CI
Dec. 05	Stoke Therapeutics and Biogen present data that further support the disease-modifying potential of zorevunersen	RE

03f152de.5-6ulqhpP0s1Cqo3ZdK7dVEky24-GMD146ESnqphAuQ.nanv1PkKaXkMWO9cXePhRmJmgi8LVqG-iOVD3foNZaPTvuGvmB1sLltV7w

Published financial data: BIOGEN INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	12.67B	10.51B	9.69B	9.84B	9.68B
Other Revenues, Total	775M	476M	485M	-	-
Total Revenues	13.44B	10.98B	10.17B	9.84B	9.68B
Cost of Goods Sold, Total	1.81B	2.11B	2.28B	2.53B	2.31B
Gross Profit	11.64B	8.87B	7.9B	7.3B	7.37B
Selling General & Admin Expenses, Total	2.51B	2.68B	2.41B	2.5B	2.39B
R&D Expenses	3.98B	2.5B	2.23B	2.46B	2.02B
Amortization of Goodwill and Intangible Assets - (IS)	255M	252M	246M	241M	386M
Other Operating Expenses	233M	7.2M	-7.4M	219M	254M
Other Operating Expenses, Total	6.98B	5.44B	4.88B	5.42B	5.04B
Operating Income	4.66B	3.44B	3.01B	1.88B	2.32B
Interest Expense, Total	-213M	-254M	-247M	-247M	-250M
Interest And Investment Income	42M	11M	89.3M	276M	67.6M
Net Interest Expenses	-171M	-243M	-157M	29.6M	-183M
Income (Loss) On Equity Invest.	5.3M	34.9M	2.6M	-	-
Currency Exchange Gains (Loss)	-10.7M	-22.4M	-35.5M	-50.4M	-30.9M
Other Non Operating Income (Expenses)	3.6M	-4M	-3M	-1.7M	-26.5M
EBT, Excl. Unusual Items	4.48B	3.2B	2.82B	1.86B	2.08B
Restructuring Charges	-	-	-131M	-243M	-73.9M
Merger & Related Restructuring Charges	-	-	-	-28.4M	-2.8M
Gain (Loss) On Sale Of Investments	686M	-825M	1.23B	-291M	-100M
Gain (Loss) On Sale Of Assets	92.5M	-	504M	-	88.6M
Asset Writedown	-210M	-629M	-120M	-	-60.2M
In Process R&D Expenses	-75M	-18M	-	-	-
Legal Settlements	-	-	-917M	-	-
Other Unusual Items	76.9M	50.7M	209M	-	-27.7M
EBT, Incl. Unusual Items	5.05B	1.78B	3.59B	1.3B	1.91B
Income Tax Expense	992M	52.5M	633M	135M	274M
Earnings From Continuing Operations	4.06B	1.73B	2.96B	1.16B	1.63B
Net Income to Company	4.06B	1.73B	2.96B	1.16B	1.63B
Minority Interest	-59.9M	-172M	85.3M	-400K	-
Net Income - (IS)	4B	1.56B	3.05B	1.16B	1.63B
Net Income to Common Incl Extra Items	4B	1.56B	3.05B	1.16B	1.63B
Net Income to Common Excl. Extra Items	4B	1.56B	3.05B	1.16B	1.63B
Per Share Items
Net EPS - Basic	24.86	10.44	20.97	8.02	11.21
Basic EPS - Continuing Operations	24.86	10.44	20.97	8.02	11.21
Basic Weighted Average Shares Outstanding	161M	149M	145M	145M	146M
Net EPS - Diluted	24.8	10.4	20.87	7.97	11.18
Diluted EPS - Continuing Operations	24.8	10.4	20.87	7.97	11.18
Diluted Weighted Average Shares Outstanding	161M	150M	146M	146M	146M
Normalized Basic EPS	17.04	12.27	12.72	8.03	8.94
Normalized Diluted EPS	17	12.23	12.66	7.98	8.92
American Depositary Receipts Ratio (ADR)	0.17	0.17	0.17	0.17	0.17
Supplemental Items
EBITDA	5.11B	3.92B	3.53B	2.38B	3B
EBITA	4.91B	3.69B	3.26B	2.12B	2.71B
EBIT	4.66B	3.44B	3.01B	1.88B	2.32B
EBITDAR	5.2B	4.02B	3.63B	2.52B	3.12B
Total Revenues (As Reported)	13.44B	10.98B	10.17B	9.84B	9.68B
Effective Tax Rate - (Ratio)	19.64	2.95	17.61	10.43	14.37
Current Domestic Taxes	688M	342M	734M	393M	499M
Current Foreign Taxes	155M	137M	67.9M	48.4M	-67.5M
Total Current Taxes	843M	479M	801M	441M	432M
Deferred Domestic Taxes	-1.76B	-254M	-326M	-600M	-172M
Deferred Foreign Taxes	1.91B	-172M	157M	294M	13.7M
Total Deferred Taxes	149M	-427M	-169M	-306M	-158M
Normalized Net Income	2.74B	1.83B	1.85B	1.16B	1.3B
Interest Capitalized	65.2M	36.3M	17.1M	21.7M	3.2M
Non-Cash Pension Expense	21.7M	29.1M	25.9M	21.2M	21.3M
Supplemental Operating Expense Items
Advertising Expense	112M	98.7M	54.1M	71.4M	66.8M
Selling and Marketing Expenses	112M	98.7M	54.1M	71.4M	66.8M
Research And Development Expense From Footnotes	4.07B	3.4B	2.6B	2.7B	2.49B
Net Rental Expense, Total	92.4M	97.9M	95.6M	140M	125M
Imputed Operating Lease Interest Expense	28.67M	29.1M	28M	42.64M	35.93M
Imputed Operating Lease Depreciation	63.73M	68.8M	67.6M	97.66M	89.37M
Stock-Based Comp., Other (Total)	205M	251M	264M	658M	342M
Total Stock-Based Compensation	205M	251M	264M	658M	342M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	1.33B	2.26B	3.42B	1.05B	2.38B
Short Term Investments	1.28B	1.54B	1.47B	-	-
Total Cash And Short Term Investments	2.61B	3.8B	4.89B	1.05B	2.38B
Accounts Receivable, Total	2.33B	1.96B	2.14B	2.1B	1.87B
Other Receivables	-	-	799M	430M	-
Total Receivables	2.33B	1.96B	2.94B	2.53B	1.87B
Inventory	1.07B	1.35B	1.34B	2.53B	2.46B
Prepaid Expenses	-	-	-	-	-
Other Current Assets, Total	881M	741M	619M	752M	752M
Total Current Assets	6.89B	7.86B	9.79B	6.86B	7.46B
Gross Property Plant And Equipment	5.63B	5.8B	5.87B	6.13B	6.21B
Accumulated Depreciation	-1.78B	-2.01B	-2.17B	-2.4B	-2.67B
Net Property Plant And Equipment	3.84B	3.79B	3.7B	3.73B	3.54B
Long-term Investments	3.67B	2.83B	1.81B	626M	424M
Goodwill	5.76B	5.76B	5.75B	6.22B	6.48B
Other Intangibles, Total	3.08B	2.22B	1.85B	8.36B	9.69B
Accounts Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	1.37B	1.42B	1.23B	929M	324M
Other Long-Term Assets, Total	-	5.5M	426M	119M	137M
Total Assets	24.62B	23.88B	24.55B	26.84B	28.05B
Liabilities
Accounts Payable, Total	455M	589M	492M	403M	424M
Accrued Expenses, Total	1.63B	1.38B	1.5B	1.45B	1.5B
Current Portion of Long-Term Debt	-	999M	-	150M	1.75B
Current Portion of Leases	83.2M	89.1M	97.2M	90.3M	86.4M
Current Income Taxes Payable	142M	175M	260M	257M	548M
Unearned Revenue Current, Total	-	-	-	-	-
Other Current Liabilities	1.43B	1.06B	928M	1.08B	1.22B
Total Current Liabilities	3.74B	4.3B	3.27B	3.43B	5.53B
Long-Term Debt	7.43B	6.27B	6.28B	6.79B	4.55B
Long-Term Leases	402M	330M	333M	400M	334M
Deferred Tax Liability Non Current	1.03B	694M	335M	642M	190M
Other Non Current Liabilities	1.33B	1.32B	944M	781M	732M
Total Liabilities	13.93B	12.92B	11.17B	12.05B	11.33B
Common Stock, Total	100K	100K	100K	100K	100K
Additional Paid In Capital	-	68.2M	73.3M	302M	569M
Retained Earnings	13.98B	13.91B	16.47B	17.63B	19.26B
Treasury Stock	-2.98B	-2.98B	-2.98B	-2.98B	-2.98B
Comprehensive Income and Other	-299M	-107M	-165M	-154M	-136M
Total Common Equity	10.7B	10.9B	13.4B	14.8B	16.72B
Minority Interest	-14.2M	63.5M	-9.5M	-	-
Total Equity	10.69B	10.96B	13.39B	14.8B	16.72B
Total Liabilities And Equity	24.62B	23.88B	24.55B	26.84B	28.05B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	152M	147M	144M	145M	146M
ECS Total Common Shares Outstanding	152M	147M	144M	145M	146M
Book Value / Share	70.21	74.12	92.98	102.14	114.65
Tangible Book Value	1.85B	2.91B	5.8B	217M	546M
Tangible Book Value Per Share	12.16	19.82	40.24	1.5	3.74
Total Debt	7.91B	7.69B	6.71B	7.43B	6.72B
Net Debt	4.53B	3B	1.11B	6.38B	4.34B
Debt Equivalent of Unfunded Proj. Benefit Obligation	25.5M	-300K	-20.9M	-58.5M	-38.5M
Debt Equivalent Oper. Leases	739M	783M	765M	1.12B	1B
Minority Interest, Total (Incl. Fin. Div)	-14.2M	63.5M	-9.5M	-	-
Equity Method Investments, Total	671M	600M	-	-	-
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	315M	350M	-	-	-
Inventories - Work In Process, Total	544M	814M	-	-	-
Inventories - Finished Goods, Total	209M	188M	-	-	-
Land - (BS)	120M	208M	202M	202M	202M
Buildings, Total	1.03B	1.7B	1.59B	1.6B	1.96B
Machinery, Total	1.09B	1.65B	1.67B	1.77B	2.17B
Full Time Employees	9.1K	9.61K	8.72K	7.57K	7.6K
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	2.4M	2.2M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	4B	1.56B	3.05B	1.16B	1.63B
Depreciation & Amortization - CF	202M	236M	272M	254M	287M
Amortization of Goodwill and Intangible Assets - (CF)	255M	252M	246M	241M	386M
Depreciation & Amortization, Total	457M	488M	518M	495M	673M
(Gain) Loss From Sale Of Asset	-92.5M	-	-504M	-	-88.6M
(Gain) Loss on Sale of Investments - (CF)	-682M	827M	-1.24B	277M	101M
Asset Writedown & Restructuring Costs	285M	647M	120M	-	60.2M
(Income) Loss On Equity Investments - (CF)	-3.3M	-34.9M	-2.6M	-	-
Stock-Based Compensation (CF)	198M	239M	254M	264M	291M
Other Operating Activities, Total	254M	63.8M	81.4M	-1.3M	361M
Change In Accounts Receivable	2.8M	325M	-203M	61.3M	222M
Change In Inventories	-316M	-462M	-320M	-131M	-274M
Change In Income Taxes	-	-	-	-	-
Change In Deferred Taxes	-67.5M	231M	-142M	-299M	78.5M
Change in Other Net Operating Assets	194M	-239M	-224M	-280M	-182M
Cash from Operations	4.23B	3.64B	1.38B	1.55B	2.88B
Capital Expenditure	-425M	-258M	-240M	-277M	-154M
Sale of Property, Plant, and Equipment	-	-	583M	-	-
Cash Acquisitions	-142M	-	-	-6.93B	-1.07B
Divestitures	-	28.1M	-	-	-
Sale (Purchase) of Intangible assets	-127M	-36.8M	-2.9M	-34.4M	-118M
Investment in Marketable and Equity Securities, Total	112M	-310M	1.21B	3.15B	552M
Other Investing Activities, Total	-26.9M	12.9M	24.4M	-11.3M	-4.7M
Cash from Investing	-609M	-564M	1.58B	-4.1B	-799M
Long-Term Debt Issued, Total	2.97B	-	-	997M	-
Total Debt Issued	2.97B	-	-	997M	-
Long-Term Debt Repaid, Total	-1.5B	-170M	-1B	-810M	-650M
Total Debt Repaid	-1.5B	-170M	-1B	-810M	-650M
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-6.68B	-1.8B	-750M	-	-
Other Financing Activities, Total	-61M	-116M	4.9M	-38M	-33.5M
Cash from Financing	-5.27B	-2.09B	-1.75B	149M	-684M
Foreign Exchange Rate Adjustments	69M	-59.8M	-55.7M	35.1M	-67.7M
Net Change in Cash	-1.58B	930M	1.16B	-2.37B	1.33B
Supplemental Items
Cash Interest Paid	273M	281M	262M	252M	245M
Cash Income Tax Paid (Refund)	907M	248M	933M	741M	355M
Levered Free Cash Flow	2.88B	2.21B	1.39B	971M	3.27B
Unlevered Free Cash Flow	3.01B	2.36B	1.54B	1.13B	3.42B
Change In Net Working Capital	6.5M	226M	879M	893M	-1.23B
Net Debt Issued / Repaid	1.47B	-170M	-1B	187M	-650M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	11.22	8.86	7.78	4.58	5.29
Return on Total Capital	15.16	11.53	9.72	5.56	6.36
Return On Equity %	33.8	15.96	24.33	8.24	10.36
Return on Common Equity	33.28	14.41	25.08	8.24	10.36
Margin Analysis
Gross Profit Margin %	86.57	80.79	77.61	74.24	76.12
SG&A Margin	18.68	24.41	23.72	25.44	24.67
EBITDA Margin %	38.03	35.73	34.73	24.17	30.96
EBITA Margin %	36.52	33.58	32.05	21.58	28
EBIT Margin %	34.63	31.29	29.63	19.14	24
Income From Continuing Operations Margin %	30.2	15.73	29.11	11.81	16.87
Net Income Margin %	29.76	14.17	29.95	11.8	16.87
Net Avail. For Common Margin %	29.76	14.17	29.95	11.8	16.87
Normalized Net Income Margin	20.39	16.66	18.17	11.81	13.45
Levered Free Cash Flow Margin	21.42	20.09	13.67	9.87	33.76
Unlevered Free Cash Flow Margin	22.41	21.54	15.18	11.44	35.38
Asset Turnover
Asset Turnover	0.52	0.45	0.42	0.38	0.35
Fixed Assets Turnover	3.58	2.88	2.71	2.65	2.66
Receivables Turnover (Average Receivables)	5.28	4.9	4.73	4.64	4.88
Inventory Turnover (Average Inventory)	1.93	1.74	1.69	1.31	0.93
Short Term Liquidity
Current Ratio	1.84	1.83	2.99	2	1.35
Quick Ratio	1.32	1.34	2.39	1.04	0.77
Operating Cash Flow to Current Liabilities	1.13	0.85	0.42	0.45	0.52
Days Sales Outstanding (Average Receivables)	69.3	74.51	77.2	78.61	75.06
Days Outstanding Inventory (Average Inventory)	189.85	209.35	215.95	278.91	395.08
Average Days Payable Outstanding	87.16	79.64	86.84	43.94	67.5
Cash Conversion Cycle (Average Days)	171.99	204.22	206.31	313.58	402.64
Long Term Solvency
Total Debt/Equity	74.03	70.19	50.13	50.19	40.18
Total Debt / Total Capital	42.54	41.24	33.39	33.42	28.66
LT Debt/Equity	73.26	60.26	49.4	48.57	29.2
Long-Term Debt / Total Capital	42.09	35.41	32.91	32.34	20.83
Total Liabilities / Total Assets	56.59	54.1	45.47	44.87	40.4
EBIT / Interest Expense	21.85	13.55	12.22	7.62	9.28
EBITDA / Interest Expense	24.42	15.86	14.71	10.2	12.47
(EBITDA - Capex) / Interest Expense	22.43	14.84	13.74	9.07	11.85
Total Debt / EBITDA	1.52	1.91	1.85	2.95	2.15
Net Debt / EBITDA	0.87	0.75	0.31	2.53	1.39
Total Debt / (EBITDA - Capex)	1.66	2.04	1.98	3.32	2.26
Net Debt / (EBITDA - Capex)	0.95	0.8	0.33	2.85	1.46
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-6.49	-18.32	-7.36	-3.32	-1.62
Gross Profit, 1 Yr. Growth %	-6.3	-23.78	-11.01	-7.51	0.87
EBITDA, 1 Yr. Growth %	-33.98	-23.26	-9.83	-32.79	26.03
EBITA, 1 Yr. Growth %	-34.99	-24.9	-11.45	-34.98	27.61
EBIT, 1 Yr. Growth %	-36.05	-26.2	-12.12	-37.64	23.39
Earnings From Cont. Operations, 1 Yr. Growth %	-31.04	-57.45	71.43	-60.78	40.53
Net Income, 1 Yr. Growth %	-32.06	-61.1	95.8	-61.89	40.57
Normalized Net Income, 1 Yr. Growth %	-38.02	-33.27	0.93	-37.14	12.01
Diluted EPS Before Extra, 1 Yr. Growth %	-21.07	-58.06	100.67	-61.81	40.28
Accounts Receivable, 1 Yr. Growth %	-5.8	-15.71	8.91	-1.7	-11.01
Inventory, 1 Yr. Growth %	32.88	26.47	-0.53	87.99	-2.65
Net Property, Plant and Equip., 1 Yr. Growth %	4.64	-1.38	-2.36	0.73	-5.15
Total Assets, 1 Yr. Growth %	-9.6	-3.01	2.83	9.33	4.49
Tangible Book Value, 1 Yr. Growth %	-54.32	57.17	99.01	-96.25	151.34
Common Equity, 1 Yr. Growth %	-19.81	1.83	22.96	10.46	12.95
Cash From Operations, 1 Yr. Growth %	-40.25	-13.95	-61.97	11.77	85.85
Capital Expenditures, 1 Yr. Growth %	-17.43	-39.24	-6.9	15.27	-44.51
Levered Free Cash Flow, 1 Yr. Growth %	-37.93	-23.4	-36.93	-30.3	236.43
Unlevered Free Cash Flow, 1 Yr. Growth %	-36.65	-21.52	-34.59	-27.27	204.2
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-0.03	-12.6	-13.01	-5.36	-2.48
Gross Profit, 2 Yr. CAGR %	0.01	-15.49	-17.64	-9.28	-3.41
EBITDA, 2 Yr. CAGR %	-14.63	-28.8	-16.84	-22.16	-7.97
EBITA, 2 Yr. CAGR %	-14.68	-30.11	-18.48	-24.13	-8.91
EBIT, 2 Yr. CAGR %	-14.47	-31.28	-19.5	-25.98	-12.28
Earnings From Cont. Operations, 2 Yr. CAGR %	-4.73	-45.84	-14.6	-18	-25.76
Net Income, 2 Yr. CAGR %	-4.98	-48.59	-12.73	-13.62	-26.81
Normalized Net Income, 2 Yr. CAGR %	-15.81	-35.69	-17.89	-20.35	-16.09
Diluted EPS Before Extra, 2 Yr. CAGR %	7.2	-42.47	-8.26	-12.46	-26.81
Accounts Receivable, 2 Yr. CAGR %	-3.23	-10.89	-4.19	3.46	-6.47
Inventory, 2 Yr. CAGR %	7.2	29.64	12.16	36.75	35.28
Net Property, Plant and Equip., 2 Yr. CAGR %	3.33	1.59	-1.87	-0.82	-2.25
Total Assets, 2 Yr. CAGR %	-1.33	-6.37	-0.13	6.03	6.88
Tangible Book Value, 2 Yr. CAGR %	-33.67	-15.26	76.86	-72.7	-69.32
Common Equity, 2 Yr. CAGR %	-9.41	-9.63	11.9	16.54	11.7
Cash From Operations, 2 Yr. CAGR %	-17.32	-28.29	-42.79	-34.8	44.13
Capital Expenditures, 2 Yr. CAGR %	-25.75	-29.17	-24.79	3.6	-20.02
Levered Free Cash Flow, 2 Yr. CAGR %	-12.92	-31.03	-30.49	-33.69	53.13
Unlevered Free Cash Flow, 2 Yr. CAGR %	-12.36	-29.48	-28.37	-31.02	48.75
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	3.08	-6.54	-10.89	-9.89	-4.13
Gross Profit, 3 Yr. CAGR %	3.03	-8.65	-14.02	-14.39	-6.01
EBITDA, 3 Yr. CAGR %	-8.2	-17.61	-23.01	-22.51	-8.6
EBITA, 3 Yr. CAGR %	-8.17	-18.23	-24.41	-24.37	-9.77
EBIT, 3 Yr. CAGR %	-7.52	-18.57	-25.45	-26.03	-12.24
Earnings From Cont. Operations, 3 Yr. CAGR %	15	-27.18	-20.47	-34.11	-1.88
Net Income, 3 Yr. CAGR %	16.36	-29.45	-19.72	-33.79	1.6
Normalized Net Income, 3 Yr. CAGR %	-7.25	-22.09	-25.23	-24.89	-10.76
Diluted EPS Before Extra, 3 Yr. CAGR %	27.66	-21.6	-12.75	-31.5	2.44
Accounts Receivable, 3 Yr. CAGR %	0.11	-7.58	-4.73	-3.37	-1.6
Inventory, 3 Yr. CAGR %	5.78	13.27	18.68	33.24	22.11
Net Property, Plant and Equip., 3 Yr. CAGR %	6.51	1.73	0.26	-1.01	-2.29
Total Assets, 3 Yr. CAGR %	1.34	-1.9	-3.39	2.93	5.51
Tangible Book Value, 3 Yr. CAGR %	-23.25	-11.57	12.64	-51.07	-42.78
Common Equity, 3 Yr. CAGR %	-5.33	-5.81	0.14	11.42	15.33
Cash From Operations, 3 Yr. CAGR %	-2.41	-16.21	-41.96	-28.48	-7.56
Capital Expenditures, 3 Yr. CAGR %	-21.18	-30.55	-22.41	-13.28	-15.87
Levered Free Cash Flow, 3 Yr. CAGR %	12.12	-16.56	-33.07	-30.38	13.94
Unlevered Free Cash Flow, 3 Yr. CAGR %	11.05	-15.53	-31.26	-27.97	13.12
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	4.55	-0.83	-3.68	-6.07	-7.62
Gross Profit, 5 Yr. CAGR %	4.09	-2.4	-5.8	-8.9	-9.93
EBITDA, 5 Yr. CAGR %	-1.86	-9.17	-11.77	-19.46	-17.29
EBITA, 5 Yr. CAGR %	-1.87	-9.52	-12.46	-20.64	-18.53
EBIT, 5 Yr. CAGR %	-1.48	-9.66	-12.53	-21.62	-20.42
Earnings From Cont. Operations, 5 Yr. CAGR %	2.48	-14.11	2.09	-23.64	-22.63
Net Income, 5 Yr. CAGR %	2.44	-15.92	3.71	-23.5	-22.63
Normalized Net Income, 5 Yr. CAGR %	-1.82	-11.85	-11.66	-21.38	-21.7
Diluted EPS Before Extra, 5 Yr. CAGR %	10.08	-9.29	11.85	-18.06	-18.67
Accounts Receivable, 5 Yr. CAGR %	8.59	2.4	-1.63	-3.31	-5.43
Inventory, 5 Yr. CAGR %	3.65	6.18	8.29	22.14	25.06
Net Property, Plant and Equip., 5 Yr. CAGR %	11.94	8.67	3.07	0.7	-0.75
Total Assets, 5 Yr. CAGR %	4.77	0.86	0.75	1.2	0.59
Tangible Book Value, 5 Yr. CAGR %	-6.71	-8.97	7.18	-44.74	-33.05
Common Equity, 5 Yr. CAGR %	2.68	-2.14	1.22	2.56	4.61
Cash From Operations, 5 Yr. CAGR %	1.54	-4.52	-21.18	-24.21	-16.49
Capital Expenditures, 5 Yr. CAGR %	-7.96	-15.97	-22.64	-18.51	-21.47
Levered Free Cash Flow, 5 Yr. CAGR %	-0.74	-10.22	-7.41	-23.87	-6.77
Unlevered Free Cash Flow, 5 Yr. CAGR %	-0.23	-9.72	-6.83	-22.1	-6.36